BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang T, Mohan C. Caution in studying and interpreting the lupus metabolome. Arthritis Res Ther 2020;22:172. [PMID: 32680552 DOI: 10.1186/s13075-020-02264-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Yoon N, Jang AK, Seo Y, Jung BH. Metabolomics in Autoimmune Diseases: Focus on Rheumatoid Arthritis, Systemic Lupus Erythematous, and Multiple Sclerosis. Metabolites 2021;11:812. [PMID: 34940570 DOI: 10.3390/metabo11120812] [Reference Citation Analysis]
2 Wang Y, Shu W, Lin S, Wu J, Jiang M, Li S, Liu C, Li R, Pei C, Ding Y, Wan J, Di W. Hollow Cobalt Oxide/Carbon Hybrids Aid Metabolic Encoding for Active Systemic Lupus Erythematosus during Pregnancy. Small 2022;:e2106412. [PMID: 35064740 DOI: 10.1002/smll.202106412] [Reference Citation Analysis]
3 Robinson G, Pineda-Torra I, Ciurtin C, Jury EC. Lipid metabolism in autoimmune rheumatic disease: implications for modern and conventional therapies. J Clin Invest 2022;132:e148552. [PMID: 35040437 DOI: 10.1172/JCI148552] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
4 Yoo JY, Groer M, Dutra SVO, Sarkar A, McSkimming DI. Gut Microbiota and Immune System Interactions.Microorganisms. 2020;8. [PMID: 33076307 DOI: 10.3390/microorganisms8101587] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 12.0] [Reference Citation Analysis]
5 Tzeng HT, Chyuan IT. Immunometabolism in systemic lupus erythematosus: Relevant pathogenetic mechanisms and potential clinical applications. J Formos Med Assoc 2021;120:1667-75. [PMID: 33836940 DOI: 10.1016/j.jfma.2021.03.019] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Coelewij L, Waddington KE, Robinson GA, Chocano E, McDonnell T, Farinha F, Peng J, Dönnes P, Smith E, Croca S, Bakshi J, Griffin M, Nicolaides A, Rahman A, Jury EC, Pineda-Torra I. Serum Metabolomic Signatures Can Predict Subclinical Atherosclerosis in Patients With Systemic Lupus Erythematosus. Arterioscler Thromb Vasc Biol 2021;41:1446-58. [PMID: 33535791 DOI: 10.1161/ATVBAHA.120.315321] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Matthiesen R, Lauber C, Sampaio JL, Domingues N, Alves L, Gerl MJ, Almeida MS, Rodrigues G, Araújo Gonçalves P, Ferreira J, Borbinha C, Pedro Marto J, Neves M, Batista F, Viana-Baptista M, Alves J, Simons K, Vaz WLC, Vieira OV. Shotgun mass spectrometry-based lipid profiling identifies and distinguishes between chronic inflammatory diseases. EBioMedicine 2021;70:103504. [PMID: 34311325 DOI: 10.1016/j.ebiom.2021.103504] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Baig S, Vanarsa K, Ding H, Titus ASCLS, Mcmahon M, Mohan C. Baseline Elevations of Leukotriene Metabolites and Altered Plasmalogens Are Prognostic Biomarkers of Plaque Progression in Systemic Lupus Erythematosus. Front Cardiovasc Med 2022;9:861724. [DOI: 10.3389/fcvm.2022.861724] [Reference Citation Analysis]